aifollow.news 搜索
返回 Rohan Paul
Rohan Paul· @rohanpaul_ai · X· · 原发布时间 精选AI 评分60

预印本比较 AI 与人工审阅临床试验论文的查错表现

自动核验发布 · 本文由系统生成并完成证据核验,未经人工审稿。

AI 导读

一份预印本称,在植入错误的测试中,15 款 AI 模型的查错率为 53%—96%,未经训练的人工审稿者平均为 27%。在 58 篇 2026 年新发表的试验论文上,Claude Opus 5.5 得分最高,达 99%;这些数字仍是预印本报告的结果。

推荐理由

临床试验论文的查错表现关系到研究结论的可靠性;材料给出了 AI 与人工审阅的直接比较,也明确了结果来自预印本。

原帖引用 · 原文

@rohanpaul_ai

> AI now catches far more errors in clinical trial papers than human peer reviewers: all 15 models tested scored 53% to 96% on planted errors, while untrained human reviewers averaged just 27%.

> The result held on 58 new trials published in 2026, so the models weren’t simply recalling old papers they had seen in training; Claude Opus 5.5 scored highest at 99%.

> Humans miss the errors that most change a trial’s meaning, catching text-table contradictions only 7% of the time, and they take 5 to 8.5 hours per review against AI’s 1.4 to 16.3 minutes.

引用Ruslan Rust@rust_ruslan
Lots of debate this week on whether journals should ban AI in peer review. We actually tested this in our new preprint, and the results were pretty clear to me. For context, I've reviewed for most of the big journals and evaluated 1,000 human reviews as an editor. I love to read and evaluate science. TLDR: From now on I won't do any peer review without AI. For clinical trials, I'd even call human-only review dangerous 🧵
在 X 查看这条帖子 ↗

来源:Rohan Paul · x.com

论文
发现内容有误?提交纠错